Over the past decade, the rate of serious mental health illness in adolescents has climbed in ways that feel hard to explain. Depression, anxiety, self-harm, suicidal behavior — these are no longer rare in high school populations. We talk about stress, social media, sleep disruption, trauma, and cultural pressures. All of that matters.
What we talk about far less often is whether biology — specifically infection-triggered immune changes — may also be part of the story for some teens.
A small but thought-provoking case series explored that possibility by looking at adolescents in a residential treatment center. These were not mildly struggling teens. These were young people whose depression, anxiety, self-injury, or suicidality were severe enough that they could not safely live at home or attend school.
Microbial Induced Autoimmune Inflammation as a Cause of Mental Illness in Adolescents: A Case Series
The study is small — only ten adolescents — so it does not prove anything. But it does ask a question that deserves more attention: could exposure to certain infections trigger immune changes that contribute to psychiatric symptoms?
The background: PANDAS, PANS, and immune cross-reactivity
Years ago, researchers described a condition called PANDAS — pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. The idea was that in some children, strep infections could trigger an immune response that accidentally cross-reacted with parts of the brain. This is called molecular mimicry — when antibodies meant to fight a microbe resemble normal human tissue closely enough that they bind to both.
Over time, it became clear that strep was not the only infection associated with sudden-onset obsessive compulsive symptoms, anxiety, tics, or behavioral regression. The broader term PANS (pediatric acute-onset neuropsychiatric syndrome) was adopted to reflect that multiple infections — viral and bacterial — can potentially trigger similar immune-mediated brain inflammation.
The mechanism that has been proposed is relatively straightforward:
- An infection occurs.
- The immune system makes antibodies.
- Some antibodies cross-react with brain proteins.
- Those antibodies alter signaling in brain circuits involved in mood, movement, and behavior.
One enzyme that often comes up in this discussion is CaMKII, which plays a role in learning, memory, and dopamine signaling. Increased CaMKII activation has been associated with OCD, tics, and related neuropsychiatric symptoms in some research settings.
This case series asked: are adolescents with severe psychiatric illness showing evidence of infection exposure and immune activation at higher rates than expected?
Who was studied?
The researchers evaluated ten adolescents, ages 14–17, living in a residential treatment facility.
All ten met DSM-5 criteria for major depressive disorder.
Seven also met criteria for generalized anxiety disorder.
Three had made serious suicide attempts.
Four engaged in self-injury.
One had tics.
Nine had no known medical disorder. On the surface, these were psychiatric cases.
What did the testing show?
The researchers looked at three broad categories:
- Evidence of prior infection exposure
- Evidence of tick-borne or Bartonella exposure
- Evidence of autoimmune brain-directed antibodies
Here’s what they found:
- 3 of 10 (30%) had elevated Anti-DNase B titers, suggesting prior exposure to group A strep.
- 2 of 10 (20%) had Lyme ImmunoBlot patterns suggesting exposure to Borrelia burgdorferi (even though results did not meet CDC surveillance criteria).
- 3 of 10 (30%) had antibodies to one or more Bartonella species.
- 9 of 10 (90%) had abnormalities on the Cunningham Panel, indicating elevated antineuronal antibodies.
- 5 of 10 (50%) had elevated CaMKII activity.
That last number is striking.
Again, this is a small group, and there was no healthy control group in this study. But the finding raises the possibility that immune-mediated brain inflammation may be present in a substantial subset of severely ill adolescents.
Why this matters
Mental illness in teens is complex. It is never one thing.
But we have historically drawn a sharp line between “psychiatric” and “medical.” That line may be more porous than we think.
There is already evidence in other conditions that infections can trigger autoimmune responses that affect the brain. We see this in rheumatic fever affecting the heart. We see it in Sydenham chorea affecting movement. We see it in autoimmune encephalitis affecting behavior and cognition.
It would not be biologically surprising if similar immune mechanisms contribute to mood disorders or anxiety in some adolescents — especially in the context of increasing infection exposure rates, environmental stressors, and epigenetic changes.
The authors are careful to say this is preliminary. It does not establish causation. It does not prove that treating infections cures depression. It does not suggest that every teen with anxiety needs a tick panel.
What it does suggest is that, in a subset of adolescents with severe, treatment-resistant psychiatric illness, immune dysregulation may be part of the picture.
A balanced perspective
There are critics of immune panels such as the Cunningham Panel. There are valid debates about sensitivity, specificity, and clinical interpretation. There are also growing data linking neuroinflammation and psychiatric illness more broadly.
The point is not to jump to conclusions.
The point is to widen the lens.
When adolescent mental health morbidity and mortality are rising at alarming rates, we cannot afford to ignore potential biological contributors simply because they complicate our existing framework.
Screen time and stress matter.
Trauma matters.
Family systems matter.
Biology may matter too.
The larger question
If exposure to microbes such as strep, Borrelia, or Bartonella can, in some cases, trigger autoimmune responses that alter dopamine signaling and brain circuitry, then the rising rates of infection and immune dysregulation in modern environments may intersect with the rising rates of psychiatric illness.
This case series does not answer that question.
It asks it more clearly.
And in medicine, sometimes asking the right question is the most important first step.